Enhancing the Pharmacokinetic Profile of Protein-based Drugs

Award Information
Agency:
Department of Defense
Branch
Office for Chemical and Biological Defense
Amount:
$499,999.00
Award Year:
2014
Program:
SBIR
Phase:
Phase II
Contract:
W911NF-14-C-0071
Award Id:
n/a
Agency Tracking Number:
C2-0391
Solicitation Year:
2012
Solicitation Topic Code:
CBD12-101
Solicitation Number:
2012.2
Small Business Information
1 Kendall Sq. Bldg. 200, Suite 2203, Cambridge, MA, 02139-
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
Y
Duns:
963416420
Principal Investigator:
Laura Ph.D.
Founder, Chief Business O
(732) 599-8581
lhales@extendbio.com
Business Contact:
Tarik Ph.D.
Founder, Chief Executive
(732) 599-8580
tsoliman@extendbio.com
Research Institute:
n/a
Abstract
Many protein-based drugs have limited efficacy due to a short half-life or require intravenous delivery because of low bioavailability. Extend Biosciences is developing proprietary carrier molecules that allow proteins to access an intrinsic transport pathway for efficient delivery to the vascular space and then maintain a sustained presence in circulation. This novel technology would be of particular importance in the development of longer-lasting versions of bioscavenger proteins that could then be delivered subcutaneously or intramuscularly and become bioavailable within minutes of administration. In this project, one of Extend Biosciences"carrier molecules will be conjugated to two bioscavenger proteins of interest to the military. The modified bioscavengers will be tested for their improved half-life and rapid bioavailability in an appropriate animal model. Safety of the modified proteins will be assessed by testing whether the modified proteins induce toxicity or an immune response. A successful project will enable the prophylactic or acute on-site treatment options to counteract the threat of intoxication and death by organophosphate compounds. This project will demonstrate the feasibility of improving the half-life and bioavailability of bioscavenger proteins that could be applied to numerous other protein-based drugs including those used in Chemical and Biological Defense treatments.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government